This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

Next Generation Organoids for Biomedical Research and Drug Discovery

Next Generation Organoids for Biomedical Research and Drug Discovery

Tuesday, November 12, 2019, 9:00 AM - 6:00 PM

The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Presented By

The Biochemical Pharmacology Discussion Group

The New York Academy of Sciences

 

Recent advances in 3D culture technology have allowed embryonic and adult mammalian stem cells to exhibit their remarkable self-organizing properties, with the resulting organoids reflecting key structural and functional properties of organs — including kidney, lung, gut, brain and retina. By mimicking the microstructures and biological functions of target organs, organoids complement or improve upon current multiscaled drug-testing platforms including in vitro molecular assays, cell platforms, and in vivo models, and modelling human organ development and various pathologies “in a dish.’’ The technology is currently being extended to develop multi-organ models that enable precise control of multicellular activities, extracellular matrix (ECM) compositions, spatial distributions of cells, architectural organizations of ECM, and environmental cues.

These engineered human organs are a remarkable tool with the potential to facilitate studies that better predict drug efficacy and thereby reduce cost, time, and failure rates in clinical trials. Further, patient-derived organoids hold promise for personalized medicine, as they have the potential to produce individualized predictions of drug response. This symposium will feature discussions on the science behind organoid models, along with their many applications in health and disease.

Call for Abstracts

Abstract submissions are invited for a poster session. For complete submission instructions, please visit our online portal. The deadline for abstract submission is Tuesday, September 17, 2019.

Registration

Member
By 10/01/2019
$90
After 10/01/2019
$130
Nonmember Academia, Faculty, etc.
By 10/01/2019
$180
After 10/01/2019
$260
Nonmember Corporate, Other
By 10/01/2019
$250
After 10/01/2019
$350
Nonmember Not for Profit
By 10/01/2019
$180
After 10/01/2019
$260
Nonmember Student, Undergrad, Grad, Fellow
By 10/01/2019
$100
After 10/01/2019
$145
Member Student, Post-Doc, Fellow
By 10/01/2019
$50
After 10/01/2019
$70
Deadline:
307
days
left

Keynote Speaker

Hans Clevers, MD, PhD,
University Medical Center Utrecht, Princess Máxima Center for Pediatric Oncology, Hubrecht Institute, and Oncode Institute

Speakers

Christopher S. Chen, MD, PhD, Boston University
Linda Griffith, PhD,
Massachusetts Institute of Technology
Bill Murphy, PhD, University of Wisconsin-Madison
Molly S. Shoichet, PhD, University of Toronto
Thaddeus Stappenbeck, MD, PhD, Washington University St Louis

Scientific Organizing Committee

Linda Griffith, PhD,
Massachusetts Institute of Technology
John Hambor, PhD,
Boehringer Ingelheim
Erick Young, PhD,
Boehringer Ingelheim
Sonya Dougal, PhD,
The New York Academy of Sciences
Alison Carley, PhD,
The New York Academy of Sciences